.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Apollo Hospitals has announced its restructuring plans to unlock significant business value. Consequently, the company proposed appointing promoter director Shobana Kamineni as the Executive Chairperson of its upcoming arm. This leadership change aligns with the upcoming Apollo Healthtech listing, which will consolidate digital health and pharmacy operations. Specifically, the corporate transition aims to establish a strong governance framework for the new entity ahead of its public debut.
The restructuring process involves the demerger of the digital health and pharmacy business. Currently, Apollo Healthtech operates in the medical equipment and digital healthcare segments. Therefore, this consolidation will bring several high-growth verticals under one umbrella. The parent company expects the entire demerger process to conclude by late FY27. Meanwhile, the entity is targeting an annualized revenue of around Rs 25,000 crore by the time of its market debut.
To ensure strong oversight, Apollo Healthtech will maintain an independent board of directors. At least half of the board members will be independent. Additionally, nomination rights for promoters and investors will remain linked to a ten percent shareholding threshold. Shobana Kamineni will drive the next phase of growth for this technology and device business. Previously, she served as a promoter director on the main board and led major digital healthcare initiatives.
Q1: What is Apollo Healthtech?
Apollo Healthtech is the restructured entity of Apollo Hospitals that consolidates its digital health platform, Apollo 24/7, offline pharmacy business, and medical equipment supply operations.
Q2: When is the listing expected to take place?
The company targets completing the demerger and listing of Apollo Healthtech by late FY27, subject to necessary shareholder and regulatory approvals.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Apollo Hospitals plans to appoint Shobana Kamineni as Executive Chairperson of Apollo Healthtech, its soon-to-be-listed digital health and pharmacy arm. The demerger aims to unlock shareholder value by late FY27, targeting an annualized revenue run rate of Rs 25,000 crore upon listing on major stock exchanges.
4 months ago
Kenya's confirmation of its eighth Ebola infection highlights the acute risk of secondary transmission in hospital environments. Clinicians must maintain high vigilance, enforce strict infection prevention protocols, and implement rapid triage mechanisms for viral hemorrhagic fevers across healthcare settings.
4 days back
Maternal anaemia contributes to nearly half of pregnancy-related fatalities across India. To prevent complications, Uttar Pradesh has added single-dose parenteral iron to its essential medicines list. This clinical transition aims to restore haemoglobin rapidly and protect high-risk mothers across rural facilities.
Last week
India's food safety authority FSSAI has issued show-cause notices to Gemini Edibles, BigBasket, and Flipkart for unpermitted cardiovascular claims regarding Freedom Rice Bran Oil. This regulatory move highlights the strict enforcement of advertising standards and the clinical necessity of evidence-based lipid care.
6 days back
The state government is deploying helicopter emergency medical services across the Mumbai-Pune Expressway, Samruddhi Mahamarg, and Mumbai-Goa Highway. This initiative establishes unified standard operating procedures to enable rapid triage, advanced prehospital resuscitation, and seamless trauma care transfers.
Last week
Atherosclerotic cardiovascular disease guidelines often rely on European-derived lipoprotein(a) cutoffs. However, baseline Lp(a) levels vary widely across ancestries, including South Asians and Africans. Clinicians must interpret Lp(a) values within overall absolute cardiovascular risk.
Last week
